Brady W. Dougan - 14 Sep 2023 Form 4 Insider Report for Humacyte, Inc. (HUMA)

Role
Director
Signature
/s/ Brady W. Dougan by Dale A. Sander as Attorney-in-Fact
Issuer symbol
HUMA
Transactions as of
14 Sep 2023
Net transactions value
-$5,560,000
Form type
4
Filing time
15 Sep 2023, 16:05:58 UTC
Previous filing
21 Aug 2023
Next filing
10 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HUMA Common Stock Sale $5,560,000 -2,000,000 -24% $2.78 6,191,140 14 Sep 2023 By Ayabudge LLC F1
holding HUMA Common Stock 510,161 14 Sep 2023 Direct
holding HUMA Common Stock 1,270,240 14 Sep 2023 By spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales were made by Ayabudge LLC, an entity controlled by Brady W. Dougan. The transactions enabled Mr. Dougan to pay down leverage while providing a mechanism for investors to acquire shares of the Issuer at a time that the Issuer was not conducting a financing transaction and was not making any additional shares available for purchase.